DURHAM – FHI 360, a Durham-based international nonprofit human development organization, has launched a subsidiary called FHI Clinical as a full-service contract research organization to manage complex clinical research in resource-limited settings around the world.
With a focus on mission-driven clinical research, FHI Clinical addresses unmet research needs across dozens of therapeutic areas, while supporting the development of life-saving vaccines and medicines. Whether working from a state-of-the-art facility or in a low-tech, rural setting, FHI Clinical intends to provide services tailored to meet its clients’ diverse study needs, from protocol design and site assessment to trial planning, implementation and management.
Ted Fitzgerald, president and CEO of the new company, transitioned from FHI 360, where he served as director of global research services.
“FHI 360’s global reach and reputation for excellence has enabled us to provide technical, regulatory and cultural expertise in regions where the needs for clinical research are greatest,” said Fitzgerald in announcing the launch this week.
“As an independent subsidiary, FHI Clinical has the best of both worlds — access to FHI 360’s global platform and technical expertise, and the flexibility to implement systems and processes designed for both commercial and public sector clients.”
For decades, Fitzgerald has been leading clinical research services, business development and administrative teams for FHI 360, which focuses on family planning, reproductive health and HIV/AIDs by advancing locally driven solutions.
FHI Clinical will join FHI 360’s family of organizations. This will include two other recently launched subsidiaries: the social impact investing company FHI Ventures, and the nonprofit FHI Partners, which creates strategic partnerships with foundations and corporations.
“FHI Clinical will enable us to further expand our social impact,” said Patrick Fine, CEO of FHI 360. “Each member of the FHI 360 family operates differently, yet together we are guided by the same vision: to create a world in which all individuals and communities have the opportunity to reach their highest potential. I’m confident that FHI Clinical will deliver on that mission.”
(C) N.C. Biotech Center